Try it as your roleGet started

Z79: Long term (current) drug therapy

Z79 is a category, not a billable code. It has 40 codes under it, 32 of them billable; a claim or a chart uses one of those.

Code set
ICD-10-CM, FY2026 (United States)
Chapter
21. Factors influencing health status and contact with health services
Section
Persons with potential health hazards related to family and personal history and certain conditions influencing health status (Z77-Z99)
Codes under it
40 (32 billable)
Notes

What Z79 covers

Includes · Conditions and terms coded here.
  • long term (current) drug use for prophylactic purposes
Excludes2 · Not part of this condition, but a patient can have both, and both may be coded.
  • drug abuse and dependence (F11-F19)
  • drug use complicating pregnancy, childbirth, and the puerperium (O99.32-)
Code also · A second code may be needed; the order depends on the encounter.
  • any therapeutic drug level monitoring (Z51.81)
Codes

Every code under Z79

CodeDescriptionBillable
Z79.0Long term (current) use of anticoagulants and antithrombotics/antiplatelets
Excludes2
  • long term (current) use of aspirin (Z79.82)
Header
Z79.01Long term (current) use of anticoagulantsBillable
Z79.02Long term (current) use of antithrombotics/antiplateletsBillable
Z79.1Long term (current) use of non-steroidal anti-inflammatories (NSAID)
Excludes2
  • long term (current) use of aspirin (Z79.82)
Billable
Z79.2Long term (current) use of antibioticsBillable
Z79.3Long term (current) use of hormonal contraceptives
Includes
  • Long term (current) use of birth control pill or patch
Billable
Z79.4Long term (current) use of insulin
Excludes2
  • long-term (current) use of injectable non-insulin antidiabetic drugs (Z79.85)
  • long term (current) use of oral antidiabetic drugs (Z79.84)
  • long term (current) use of oral hypoglycemic drugs (Z79.84)
Billable
Z79.5Long term (current) use of steroidsHeader
Z79.51Long term (current) use of inhaled steroidsBillable
Z79.52Long term (current) use of systemic steroidsBillable
Z79.6Long term (current) use of immunomodulators and immunosuppressants
Excludes2
  • long term (current) use of steroids (Z79.5-)
  • long term (current) use of agents affecting estrogen receptors and estrogen levels (Z79.81-)
Header
Z79.60Long term (current) use of unspecified immunomodulators and immunosuppressantsBillable
Z79.61Long term (current) use of immunomodulator
Includes
  • Long term (current) use of apremilast
  • Long term (current) use of immunomodulatory imide drug
  • Long term (current) use of lenalidomide
  • Long term (current) use of pomalidomide
Billable
Z79.62Long term (current) use of immunosuppressantHeader
Z79.620Long term (current) use of immunosuppressive biologic
Includes
  • Long term (current) use of adalimumab
  • Long term (current) use of etanercept
  • Long term (current) use of infliximab
  • Long term (current) use of monoclonal antibodies
Billable
Z79.621Long term (current) use of calcineurin inhibitor
Includes
  • Long term (current) use of cyclosporine
  • Long term (current) use of tacrolimus
Billable
Z79.622Long term (current) use of Janus kinase inhibitor
Includes
  • Long term (current) use of tofacitinib
Billable
Z79.623Long term (current) use of mammalian target of rapamycin (mTOR) inhibitor
Includes
  • Long term (current) use of sirolimus
Billable
Z79.624Long term (current) use of inhibitors of nucleotide synthesis
Includes
  • Long term (current) use of azathioprine
  • Long term (current) use of mycophenolate
  • Long term (current) use of purine synthesis (IMDH) inhibitors
Billable
Z79.63Long term (current) use of chemotherapeutic agentHeader
Z79.630Long term (current) use of alkylating agent
Includes
  • Long term (current) use of chlorambucil
  • Long term (current) use of cisplatin
  • Long term (current) use of cyclophosphamide
Billable
Z79.631Long term (current) use of antimetabolite agent
Includes
  • Long term (current) use of 5-fluorouracil
  • Long term (current) use of 6-mercaptopurine
  • Long term (current) use of cytarabine
  • Long term (current) use of methotrexate
Billable
Z79.632Long term (current) use of antitumor antibiotic
Includes
  • Long term (current) use of bleomycin
  • Long term (current) use of doxorubicin
  • Long term (current) use of mitomycin C
Billable
Z79.633Long term (current) use of mitotic inhibitor
Includes
  • Long term (current) use of paclitaxel
  • Long term (current) use of plant alkaloids
  • Long term (current) use of vinblastine
  • Long term (current) use of vincristine
Billable
Z79.634Long term (current) use of topoisomerase inhibitor
Includes
  • Long term (current) use of etoposide
  • Long term (current) use of irinotecan
  • Long term (current) use of topotecan
Billable
Z79.64Long term (current) use of myelosuppressive agent
Includes
  • Long term (current) use of hydroxyurea
Billable
Z79.69Long term (current) use of other immunomodulators and immunosuppressantsBillable
Z79.8Other long term (current) drug therapyHeader
Z79.81Long term (current) use of agents affecting estrogen receptors and estrogen levels
Excludes1
  • hormone replacement therapy (Z79.890)
Code first
  • , if applicable:
  • malignant neoplasm of breast (C50.-)
  • malignant neoplasm of prostate (C61)
Use additional code
  • code, if applicable, to identify:
  • estrogen receptor positive status (Z17.0)
  • family history of breast cancer (Z80.3)
  • genetic susceptibility to malignant neoplasm (cancer) (Z15.0-)
  • personal history of breast cancer (Z85.3)
  • personal history of prostate cancer (Z85.46)
  • postmenopausal status (Z78.0)
Header
Z79.810Long term (current) use of selective estrogen receptor modulators (SERMs)
Includes
  • Long term (current) use of raloxifene (Evista)
  • Long term (current) use of tamoxifen (Nolvadex)
  • Long term (current) use of toremifene (Fareston)
Billable
Z79.811Long term (current) use of aromatase inhibitors
Includes
  • Long term (current) use of anastrozole (Arimidex)
  • Long term (current) use of exemestane (Aromasin)
  • Long term (current) use of letrozole (Femara)
Billable
Z79.818Long term (current) use of other agents affecting estrogen receptors and estrogen levels
Includes
  • Long term (current) use of estrogen receptor downregulators
  • Long term (current) use of fulvestrant (Faslodex)
  • Long term (current) use of gonadotropin-releasing hormone (GnRH) agonist
  • Long term (current) use of goserelin acetate (Zoladex)
  • Long term (current) use of leuprolide acetate (leuprorelin) (Lupron)
  • Long term (current) use of megestrol acetate (Megace)
Billable
Z79.82Long term (current) use of aspirinBillable
Z79.83Long term (current) use of bisphosphonatesBillable
Z79.84Long term (current) use of oral hypoglycemic drugs
Includes
  • Long term (current) use of oral antidiabetic drugs
Excludes2
  • long-term (current) use of injectable non-insulin antidiabetic drugs (Z79.85)
  • long term (current) use of insulin (Z79.4)
Billable
Z79.85Long-term (current) use of injectable non-insulin antidiabetic drugs
Excludes2
  • long term (current) use of insulin (Z79.4)
  • long term (current) use of oral hypoglycemic drugs (Z79.84)
Billable
Z79.89Other long term (current) drug therapyHeader
Z79.890Hormone replacement therapyBillable
Z79.891Long term (current) use of opiate analgesic
Includes
  • Long term (current) use of methadone for pain management
Excludes1
  • methodone use NOS (F11.9-)
  • use of methodone for treatment of heroin addiction (F11.2-)
Billable
Z79.899Other long term (current) drug therapyBillable
In MedAppz

Where these codes are used

A diagnosis is coded on the visit note in CaseNotes, a coder works through discharged stays in MRDTracker, and a US practice’s claims carry the chart’s ICD-10-CM codes in US Claims. India and most other countries report in WHO’s ICD-10 or ICD-11; MedAppz loads ICD-11 today, and WHO’s ICD-10 file is still to come.

From the ICD-10-CM FY2026 tabular list published by CDC’s National Center for Health Statistics (a US government work, free to reuse). Check the release in force before you code a claim. The source file